Evaluation of the effectiveness and tolerability of controlled-release diclofenac-potassium versus immediate-release diclofenac-potassium in the treatment of knee osteoarthritis

Current Therapeutic Research - Clinical and Experimental

Volumn 68, Issue 2, 2007, Pages 82-93

  Herrera, José A ^a   Millán, Alberto ^b   Ramos, Rómulo ^c   Fuentes, Palmenia ^c   González, María ^d  

^a Hospital Dr José María Vargas de Caracas   (Venezuela)

^b Centro Medico Docente La Trinidad   (Venezuela)

^c Hospital Dr Domingo Luciani   (Venezuela)

^d SAV   (Venezuela)

Author keywords

controlled release; diclofenac potassium; immediate release; osteoarthritis

Indexed keywords

DICLOFENAC POTASSIUM; PARACETAMOL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOTTING TEST; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; HEARTBURN; HEMATOLOGY; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; VISUAL ANALOG SCALE;

EID: 34547584518     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2007.03.004     Document Type: Article

References (28)

1. (Suppl). Buckwalter J., Saltzman C., and Brown T. The impact of osteoarthritis: Implications for research. Clin Orthop Relat Res 427 (2004) S6-S15
2. Buckwalter J., and Mankin H. Articular cartilage. Part II: Degeneration and osteoarthrosis, repair, regeneration, and transplantation. J Bone Joint Surg 79 (1997) 612-632
3. Altman R. Measurement of structure (disease) modification in osteoarthritis. Osteoarthritis Cartilage 12 Suppl 1 (2004) 69-76
4. Felson D., Zhang Y., Hannan M., et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 38 (1995) 1500-1505
5. Valdes A., Hart D., Jones K., et al. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 50 (2004) 2497-2507
6. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis Rheum 43 (2000) 1905-1915
7. Pendleton A., Arden N., Dougados M., et al. EULAR recommendations for the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59 (2000) 936-944
8. Hochberg M., and Dougados M. Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol 15 (2001) 583-593
9. Lee C., Straus W., Balshaw R., et al. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: A meta-analysis. Arthritis Rheum 51 (2004) 746-754
10. Dominick K., Bosworth H., Jeffreys A., et al. Racial/ethnic variations in nonsteroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis. Pharmacoepidemiol Drug Saf 13 (2004) 683-694
11. Case J., Baliunas A., and Block J. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: A randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 163 (2003) 169-178
12. CD004257. Towheed T., Judd M., Hochberg M., and Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2 (2003)
13. Porto A., Reis C., Perdigoto R., et al. Gastroduodenal tolerability of nimesulide and diclofenac in patients with osteoarthritis. Curr Ther Res Clin Exp 59 (1998) 654-665
14. for the CAPSS-105 Study Group. Silverfield J., Kamin M., Wu S., and Rosenthal N. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 24 (2002) 282-297
15. Bourgeois P., Dreiser R., Lequesne M., et al. Multi-centre double-blind study to define the most favorable dose of nimesulide in terms of efficacy/safety ratio in the treatment of osteoarthritis. Eur J Rheumatol Inflamm 14 (1994) 39-50
16. Ku E., Kothari H., Lee W., et al. Effects of diclofenac sodium on arachidonic acid metabolism. Agents Actions Suppl 17 (1985) 189-193
17. Cashman J. The mechanisms of action of NSAIDs in analgesia. Drugs 52 Suppl 5 (1996) 13-23
18. Kothari H., Lee W., and Ku E. An alternative mechanism for regulation of leukotriene production in leukocytes: Studies with an anti-inflammatory drug, sodium diclofenac. Biochim Biophys Acta 921 (1987) 502-511
19. Todd P., and Sorkin E. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 35 (1988) 244-285
20. Orozco M. Diclofenac potásico A.P. Guarenas, Estado Miranda, Venezuela: Informe Laboratorios Leti, S.A.V.
21. Physician's Desk Reference Companion Guide. 53rd ed. (1999), Medical Economics, Montvale, NJ
22. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284 (2000) 3043-3046
23. International Committee on Harmonization. Harmonized tripartita. Guideline for Good Clinical Practice (2000), Glaxo-Welcome, Inc, Research Triangle Park, NC
24. for the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Altman R., Asch E., Bloch D., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986) 1039-1049
25. Ingvarsson T., Hägglund G., Lindberg H., and Lohmander S. Assessment of primary hip osteoarthritis: Comparison of radiographic methods using colon radiographs. Ann Rheum Dis 59 (2000) 650-653
26. Bellamy N., Buchanan W., Goldsmith C., et al. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
27. Chacon J., Gonzalez N., Veliz A., et al. Effect of knee osteoarthritis on the perception of quality of life in Venezuelan patients. Arthritis Rheum 51 (2004) 377-382
28. Bonnet C., and Walsh D. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44 (2005) 7-16